Certara
Princeton
About Certara
Certara is a pharmaceutical company that accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries. Certara's end-to-end platform includes biosimulation, regulatory science, and market access solutions. It integrates its unique portfolio of software and technology-enabled services spanning discovery to post-approval.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $844.2M
- Funding stage: M&A
- Last round: Post-IPO Equity (Mar 2025)
- Ticker: nasdaq:CERT
- Website: certara.com
- Phone: 415-237-8272
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Software
Social Profiles
Canonical: https://fsome.com/organization/certara-124173 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.